Benjamin Basil

Benjamin Basil has extensive experience in the pharmaceutical industry, with a notable tenure at Eli Lilly and Company from August 1999 to January 2024. In the role of Senior Vice President, Global Customer Office, Benjamin transformed patient outreach for innovative medicines. Benjamin also served as President & General Manager of Eli Lilly China, leading the company's largest international market, and as President & GM for Australia, New Zealand, & North Asia Pacific, where sales revenue grew by double digits. Other key positions included US Oncology Marketing Leader, where Benjamin launched a blockbuster breast cancer product, and US Alzheimer's Marketing Leader, overseeing the commercialization of pioneering treatments. Earlier roles encompassed various marketing and sales positions, achieving top-tier performance. Education includes an MBA in Global Marketing and International Business from UNC Kenan-Flagler Business School and Executive Education from Harvard Business School in Leading Global Businesses.